Philippe Morain Selected Research

S18986-1

10/2010	DRUG FOCUS: S 18986: A positive allosteric modulator of AMPA-type glutamate receptors pharmacological profile of a novel cognitive enhancer.
5/2008	The AMPA modulator S 18986 improves declarative and working memory performances in aged mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philippe Morain Research Topics

Disease

6	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2009
3	Cognitive Dysfunction 01/2017 - 01/2002
2	Dementia (Dementias) 01/2017 - 03/2008
2	Memory Disorders (Memory Loss) 10/2010 - 05/2008
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2010 - 01/2002
1	Parkinson Disease (Parkinson's Disease) 11/2006

Drug/Important Bio-Agent (IBA)

4	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2022 - 01/2009
4	S 24795IBA 03/2010 - 03/2008
3	Amyloid beta-PeptidesIBA 01/2017 - 01/2009
2	ApolipoproteinsIBA 01/2022 - 01/2017
2	S18986-1IBA 10/2010 - 05/2008
1	oxidized low density lipoproteinIBA 01/2017
1	Apolipoproteins E (ApoE)IBA 01/2017
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2017
1	Apolipoprotein E4IBA 01/2017
1	AMPA Receptors (AMPA Receptor)IBA 10/2010
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2009
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2009
1	Dopamine Agonists (Dopamine Agonist)IBA 11/2006
1	Levodopa (L Dopa)FDA LinkGeneric 11/2006
1	Piribedil (Trivastal)IBA 11/2006
1	S 17092-1IBA 01/2002
1	NeuropeptidesIBA 01/2002

Therapy/Procedure

1	Therapeutics 11/2006